# Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

> **NCT02627573** · PHASE2 · TERMINATED · sponsor: **St. Petersburg State Pavlov Medical University** · enrollment: 32 (actual)

## Conditions studied

- Leukemia, Chronic Myeloid
- Myelodysplastic Syndromes
- Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

## Interventions

- **PROCEDURE:** Unrelated allogeneic stem cell transplantation
- **DRUG:** Busulfan
- **DRUG:** Fludarabine monophosphate
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Cyclophosphamide
- **DRUG:** Thymoglobulin

## Key facts

- **NCT ID:** NCT02627573
- **Lead sponsor:** St. Petersburg State Pavlov Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2019-04-03
- **Final completion:** 2019-04-03
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2019-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627573, "Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02627573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*